Skip to main content

Table 2 Odds ratio (OR) and 95% confidence intervals (CIs) for anxiety across the quintuples (Q) of energy-adjusted dietary fatty acid intake

From: Higher dietary fat quality is associated with lower anxiety score in women: a cross-sectional study

 

Q1

(n = 60)

Q2

(n = 60)

Q3

(n = 60)

Q4

(n = 60)

Q5

(n = 60)

p-trend

Total fat (non-case/case)

(43/17)

(39/21)

(35/25)

(32/28)

(38/22)

 

Model 1

1.00

1.36 (0.62–2.94)

1.80 (0.84–3.86)

2.21 (1.03–4.71)

1.46 (0.67–3.15)

0.1

P-value

 

0.4

0.1

0.1

0.4

 

Model 2

1.00

1.23 (0.55–2.73)

1.77 (0.79–3.96)

1.81 (0.82–3.98)

1.20 (0.56–2.66)

0.4

P-value

 

0.6

0.1

0.1

0.6

 

SFAs (non-case/case)

(44/16)

(43/17)

(35/25)

(37/23)

(28/32)

 

Model 1

1.00

1.08 (0.48–2.42)

1.96 (0.91–4.23)

1.66 (0.76–3.60)

3.25 (1.51–7.02)

0.001

P-value

 

0.8

40.08

0.1

0.003

 

Model 3: model 2 + MUFAs, PUFAs, Trans

1.00

1.36 (0.59–3.12)

2.12 (0.96–4.69)

1.66 (0.75–3.70)

3.17 (1.43–7.00)

0.005

P-value

 

0.4

0.06

0.2

0.004

 

MUFAs (non-case/case)

(29/31)

(38/22)

(39/21)

(39/22)

(42/17)

 

Model 1

1.00

0.54 (0.26–1.12)

0.50 (0.24–1.04)

0.52 (0.25–1.09)

0.37 (0.17–0.80)

0.02

P-value

 

0.6

0.6

0.02

0.2

 

Model 4: model 2 + SFAs, PUFAs, Trans

1.00

0.41 (0.19–0.90)

0.36 (0.16–0.82)

0.34 (0.15–0.77)

0.15 (0.05–0.44)

0.001

P-value

 

0.02

0.01

0.01

0.001

 

Oleic acid (non-case/case)

(25/35)

(38/22)

(40/20)

(41/19)

(43/17)

 

Model 1

1.00

0.42 (0.20–0.88)

0.34 (0.16–0.73)

0.33 (0.15–0.69)

0.28 (0.13–0.60)

0.001

P-value

 

0.02

0.005

0.004

0.001

 

Model 4: model 2 + SFAs, PUFAs, Trans

1.00

0.43 (0.20–0.92)

0.33 (0.15–0.72)

0.28 (0.12–0.64)

0.25 (0.09–0.67)

0.002

P-value

 

0.03

0.006

0.002

0.006

 

PUFAs (non-case/case)

(32/28)

(39/21)

(44/16)

(30/30)

(42/18)

 

Model 1

1.00

0.61 (0.29–1.28)

0.41 (0.19–0.89)

1.14 (0.55–2.34)

0.49 (0.23–1.03)

0.3

P-value

 

0.1

0.02

0.7

0.06

 

Model 5: model 2 + SFAs, MUFAs, Trans

1.00

0.96 (0.41–2.23)

1.71 (0.72–4.05)

2.35 (0.99–5.58)

1.49 (0.53–4.14)

0.1

P-value

 

0.9

0.2

0.052

0.4

 

Dietary cholesterol (non-case/case)

(42/18)

(34/26)

(41/19)

(38/22)

(32/28)

 

Model 1

1.00

1.78 (0.84–3.78)

1.08 (0.49–2.34)

1.35 (0.63–2.89)

2.04 (0.96–4.32)

0.1

P-value

 

0.1

0.8

0.4

0.06

 

Model 6: model 2 + SFAs, PUFAs, MUFAs, Trans

1.00

1.91 (0.83–4.41)

0.92 (0.38–2.22)

0.93 (0.38–2.20)

0.98 (0.39–2.50)

0.4

P-value

 

0.2

0.5

0.6

0.7

 

n-3 PUFAs (non-case/case)

(36/24)

(35/25)

(47/13)

(32/28)

(37/23)

 

Model 1

1.00

1.07 (0.51–2.21)

0.41 (0.18–0.92)

1.31 (0.63–2.70)

0.93 (0.44–1.94)

0.9

P-value

 

0.8

0.03

0.4

0.8

 

Model 7: model 2 + SFAs, MUFAs, Trans, n-6

1.00

1.05 (0.46–2.40)

0.37 (0.15–0.94)

0.92 (0.38–2.26)

0.66 (0.21–2.04)

0.4

P-value

 

0.8

0.03

0.8

0.4

 

ALA (non-case/case)

(24/36)

(35/25)

(28/32)

(46/14)

(54/6)

 

Model 1

1.00

0.44 (0.21–0.92)

0.73 (0.35–1.51)

0.18 (0.08–0.40)

0.08 (0.03–0.21)

 < 0.001

P-value

 

0.02

0.3

 < 0.001

 < 0.001

 

Model 7: model 2 + SFAs, MUFAs, Trans, n-6

1.00

0.34 (0.15–0.79)

0.59 (0.25–1.39)

0.14 (0.05–0.37)

0.07 (0.02–0.23)

 < 0.001

P-value

 

0.6

0.6

0.1

 < 0.001

 

DHA (non-case/case)

(34/26)

(38/22)

(39/21)

(32/28)

(44/16)

 

Model 1

1.00

0.75 (0.36–1.57)

0.70 (0.33–1.47)

1.14 (0.55–2.35)

0.47 (0.22–1.02)

0.2

P-value

 

0.4

0.3

0.7

0.05

 

Model 7: model 2 + SFAs, MUFAs, Trans, n-6

1.00

0.77 (0.34–1.73)

0.94 (0.41–2.15)

1.29 (0.57–2.90)

0.59 (0.25–1.40)

0.6

P-value

 

0.5

0.8

0.5

0.2

 

EPA (non-case/case)

(33/27)

(39/21)

(37/23)

(36/24)

(42/18)

 

Model 1

1.00

0.65 (0.31–1.37)

0.76 (0.36–1.57)

0.81 (0.39–1.68)

0.52 (0.24–1.11)

0.2

P-value

 

0.2

0.4

0.5

0.09

 

Model 7: model 2 + SFAs, MUFAs, Trans, n-6

1.00

0.63 (0.27–1.44)

0.93 (0.41–2.12)

0.78 (0.35–1.75)

0.62 (0.26–1.48)

0.4

P-value

 

0.2

0.8

0.5

0.2

 

n-6 PUFAs (non-case/case)

(40/20)

(40/20)

(35/25)

(34/26)

(38/22)

 

Model 1

1.00

1.00 (0.46–2.13)

1.42 (0.68–3.00)

1.52 (0.72–3.20)

1.15 (0.54–2.45)

0.4

P-value

 

1.0

0.3

0.2

0.7

 

Model 8: model 2 + SFAs, MUFAs, Trans, n-3

1.00

0.89 (0.37–2.10)

1.56 (0.65–3.71)

1.61 (0.65–4.00)

1.24 (0.38–4.08)

0.3

P-value

 

0.7

0.3

0.2

0.7

 

n-3: n-6 (non-case/case)

(34/26)

(33/27)

(33/27)

(47/13)

(40/20)

 

Model 1

1.00

1.07 (0.5–2.2)

1.07 (0.5–2.2)

0.3 (0.16–0.80)

0.6 (0.31–1.37)

0.02

P-value

 

0.85

0.85

0.01

0.26

 

Model 5: model 2 + SFAs, MUFAs, Trans

1.00

0.97 (0.42–2.23)

0.94 (0.41–2.17)

0.36 (0.15–0.88)

0.56 (0.24–1.03)

0.02

P-value

 

0.9

0.9

0.02

0.1

 
  1. Model 1: Crude
  2. Model 2 Adjusted for age, physical activity, total energy intake, job, body mass index, and parity
  3. SFAs saturated fatty acids, MUFAs monounsaturated fatty acids, PUFAs polyunsaturated fatty acids, ALA alpha-linolenic acid, DHA docosahexaenoic acid, EPA eicosapentaenoic acids